24/7 Clinical Command Center
Around-the-clock monitoring by ED and ICU-trained RNs licensed in all 50 states with AI-powered efficiency
Service · Cloud SaaSCompany source
Company profile
About Current Health
Current Health provides AI-enabled remote management technology to make high-cost therapies and complex care safe, scalable, and accessible.
Company description Current Health official website
Primary marketRemote Patient Monitoring & Wearables
Commercial modelCommercial information available on request
Company presenceLinkedIn
Work at Current Health?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- bispecific antibody therapy complications
- CAR-T therapy complications
- Cytokine Release Syndrome (CRS)
- general clinical deterioration
- ICANS (neurotoxicity)
- infectious complications
- sepsis
Who it serves
- Academic Medical Centers
- Community Hospitals
- Health Systems
- Life Sciences
- MSOs
- Pharma
- Physician Groups
Deployment & integration
Cloud Saas · Embedded · Hybrid deployment with recorded integration context.
Recorded integration context: Cerner, Epic, Meditech.
Geographic context
Markets50 state nursing licensure · United States
Company sourceOfficial website
Company milestones
Platform expansion
Partnership with Cardinal Health Velocare to scale Hospital-at-Home announced. 54 peer-reviewed publications in last 36 months. Mass General Brigham achieved 200% program growth in 15 months. 80,000 patients cared for on platform.
Partnerships
Recorded partners
- Cardinal Health Velocare
- Mass General Brigham
- Sarah Cannon Cancer Institute
- UMass Memorial Health
- Virtua Health
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
AI-Enabled Care Operations
AI-powered staff scheduling, route planning, and service coordination for scalable high-acuity home care
Software · Cloud SaaSCompany source
CRS Detection AI Algorithm
Machine learning algorithm detecting cytokine release syndrome hours earlier than clinical observation
Software · Cloud SaaSCompany source
Current Health Remote Monitoring Platform
AI-enabled remote management technology for high-cost therapies and complex care in ambulatory, home, and community settings
Platform · HybridCompany source
FDA-Cleared Passive Wearable
Proprietary upper-arm wearable for passive monitoring of critical vitals without patient burden
Device · EmbeddedCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Detection of cytokine release syndrome using wearables and cytokine profiling following CAR-T therapy for myeloma.JCI insight · Jun 22, 2026
Digital Biomarkers of Cytokine Release Syndrome: Scoping Review and Ontology Development of the Role and Relevance of Digital Measures Using a Mixed Methods Approach.Journal of medical Internet research · Dec 11, 2025
Adolescents' interactive electronic device use, sleep and mental health: a systematic review of prospective studies.Journal of sleep research · Oct 1, 2023
Remote patient monitoring to facilitate same-day discharge after laparoscopic sleeve gastrectomy: a pilot evaluation.Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery · Sep 1, 2023
Financial and Clinical Impact of Virtual Care During the COVID-19 Pandemic: Difference-in-Differences Analysis.Journal of medical Internet research · Jan 25, 2023
Healthcare provider experiences of deploying a continuous remote patient monitoring pilot program during the COVID-19 pandemic: a structured qualitative analysis.Frontiers in digital health · Jan 1, 2023
Clinical validation
Clinical-trial records
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)NCT07359846 · Mentioned · RECRUITING
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)NCT07276724 · Mentioned · RECRUITING
Transition to KPL-387 Monotherapy Dosing & Administration StudyNCT07288216 · Mentioned · RECRUITING
Intrathecal Therapy Versus Standard Care for Severe Cancer PainNCT07691840 · Mentioned · RECRUITING
Interprofessional Health Needs Assessment (IHNA) for Older Adults Living at HomeNCT07686172 · Mentioned · RECRUITING
Contextual Factors-Enriched Standard Care on Mechanical Neck PainNCT06361472 · Mentioned · RECRUITING
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
90%+ of CAR-T therapies shifted to outpatient
Sarah Cannon Cancer Institute
1,200 bed days saved in first 100 patients
Sarah Cannon Cancer Institute
25,000+ bed days saved
Mass General Brigham
Average daily census of 49 patients
Mass General Brigham Hospital at Home
Lower-than-average readmission rates
Mass General Brigham
Zero unexpected mortality
Mass General Brigham
Hours earlier CRS detection than standard of care
Clinical research
2.3 minute alarm response time
Clinical command center
200% growth in 15 months
Mass General Brigham program expansion
Mass General Brigham
Scaled Hospital at Home program to become one of the nation's largest, demonstrating clinical safety and scalability
25,000+ bed days saved, average daily census of 49+ patients, lower-than-average readmission rate, zero unexpected mortality, 200% growth in 15 months
Sarah Cannon Cancer Institute
Shifted CAR-T therapies from inpatient to outpatient settings to eliminate bed dependency and improve patient experience
90%+ of patients treated outpatient, 1,200 bed days saved in first 100 patients, 72%+ of patients stayed home for 72+ hours
UMass Memorial Health
Implemented Hospital at Home program using Current Health technology for home-based acute care
Virtua Health
Deployed Hospital at Home program with real-time patient monitoring and data documentation
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
06 · Company updates
Updates from Current Health
Recent articles published on Current Health's official website.
CAR-T in Community Settings: Expanding Access with Proven Safety
Read on Current HealthCurrent Health taps Cardinal Health to scale Hospital at Home
Read on Current HealthNow Available: Program Quality Dashboards from Current Health
Read on Current HealthWebinar: Migrating Advanced Therapies Outpatient: Operational Insights from UCSF
Read on Current Health07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Remote Patient Monitoring & Wearables
Companies providing AI-powered remote patient monitoring solutions, wearable health devices with AI analytics, continuous health tracking, or platforms that monitor patients outside clinical settings. Includes general wellness wearables with AI coaching, respiratory monitoring devices, and connected health platforms that aggregate and analyze physiological data from sensors.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.